Products Categories
  • Ms.Katrina
    Tel: 86-021-51976356

  • Mobile:86+18817383418
  • Tel:86-021-51976356
  • Fax:86-021-51976361
  • Province/state:Shanghai
  • City:Shanghai
  • Street:No1088 New Jin Qiao Road, Pudong New District, Shanghai, China
  • MaxCard:
Home > Products >  SR9009

SR9009 CAS NO.1379686-30-2

  • FOB Price: USD: 1.00-1.00 /Kilogram Get Latest Price
  • Min.Order: 1 Kilogram
  • Payment Terms: L/C,D/A,D/P,T/T,MoneyGram
  • Available Specifications:

    98%(1-100)Kilogram

  • Product Details

Keywords

  • sarms
  • puresynmr
  • Product No.: PURSR90

Quick Details

  • ProName: SR9009
  • CasNo: 1379686-30-2
  • Appearance: white power
  • Application: under development at The Scripps Resea...
  • DeliveryTime: immediately
  • PackAge: 1kg/bag,10kg/bag,25kg/bag,or as reques...
  • Port: main China port
  • ProductionCapacity: 500 Kilogram/Month
  • Purity: 98%
  • Storage: enough
  • Transportation: EMS as requested
  • LimitNum: 1 Kilogram
  • lose weight: Increasing bone mineral density

Superiority

High purity

Good research and development team

Excellent promotion team

Details

Product Introduction

What is Ostarine

 

SR9009 is an investigational Selective Androgen Receptor Modulator (SARM) developed by the Scripps Research Institute. SR9009 can help to reduce body fat without any complicated diet plans or intense workouts. It even helps with muscle development.

 

A drug known as SR9009, which is currently under increases the level of metabolic activity in skeletal muscles. It also effects can be obtained, the reversal of obesity, metabolic syndrome, and perhaps Type-II diabetes patient might be welcome it.

 

some studies showing , the SR9009 drug may offer new therapies for obesity and its companions, metabolic syndrome and diabetes. Another area in which SR9009 or a similar drug may confer substantial benefit is to offset the loss of general muscle conditioning which occurs as a side effect of reduced activity caused by illness and/or aging. People most likely to enjoy these benefits include those suffering from severe arthritis, congestive heart failure, chronic obstructive pulmonary disease (COPD), and other conditions that restrict the ability to exercise.

 

 

How it works

 

SR9009 treatment was shown to increase endurance and reverse mitochondrial damage in studies.

 

SR9009 has great promise in increased exercise capacity and endurance. This compound acts as an agonist of Rev-erbα.  SR9009 binds to one of the body’s natural molecules called Rev-erbα, which influences lipid and glucose metabolism in the liver, the production of fat-storing cells and the response of macrophages (cells that remove dying or dead cells) during inflammation.

 

Current studies show activation of Rev-erbα with SR9009 led to increased metabolic activity in skeletal muscle in culture,had a 50 percent increase in running capacity, measured by both time and distance.

 

SR9009 is an easy to dose oral compound that boosts metabolic activity in current studies.

 

SR9009 latches onto Rev-erbα -- which plays a role in regulating the body's circadian rhythm and metabolism -- resulting in a pronounced metabolic boost in test subjects.

 

 

 

Dosages and Suggestion

 

Dosages of 20-100mg a day have been reported by users without any negative side effects.  From the information we have received, results from SR9009 treatment appear to be dose dependent up to a maximum dosage of 100mg per day. After this dosage, results tend to taper off.

 

 

SARMS We offer

 

AICAR

2627-69-2

acts by entering nucleoside pools, significantly increasing levels of adenosine during periods of ATP breakdown

MK2866

841205-47-8

medical prescription for prevention of cachexia, atrophy, and sarcopenia and for Hormone or Testoserone Replacement Therapy.

MK-677

15972-10-0

A growth hormone secretagogue, treatment of obesity, a promising therapy for the treatment of frailty in the elderly

LGD-4033

1165910-22-4

pharmacological profile similar to that of enobosarm, Ostarine,MK-2866

GW1516

317318-70-0

For obesity, diabetes, dyslipidemia and cardiovascular disease

Andarine(S4)

401900-40-0

partial agonist, intended mainly for treatment of benign prostatic hypertrophy

SR9009

1379686-30-2

under development at The Scripps Research Institute (TSRI), increases the level of metabolic activity in skeletal muscles of mice

SR9011

1379686-30-2

For obesity, diabetes, dyslipidemia and cardiovascular disease

RAD140

1182367-47-0

New generation for gaining mass and cutting edges

YK11

366508-78-3

431579-34-9

YK11: a SARM and myostatin inhibitor in one

GHRP-2

158861-67-7

Growth Hormone Releasing Peptide-2

GHRP-6

87616-84-0

Growth Hormone Releasing Peptide-6

TB500

107761-42-2

Thymosin beta 4

SM130,686

/

/

 

Other products of this supplier

lookchemhot product CAS New CAS Cas Database Article Data Chemical Catalog